Thomas Wissel
7Patents
3h-index
13Co-inventors
54Inventor score
Filing activity: Jun 6, 1995 → Nov 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7951910B2 | Peptides with the marburg I polymorphism of factor VII-activating protease (FSAP) and their preparation and uses | Emerging Cross-Sectional Technologies | 11 | Active |
| US8889370B2 | Method of determining inhibitors of coagulation | Chemistry; Metallurgy | 8 | Active |
| US6376209B2 | Increasing the FVII sensitivity of a thromboplastin reagent | Physics | 5 | Expired |
| US7622558B2 | Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and use | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7029856B1 | Methods for determination of an analyte | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7700298B2 | Methods for determination of an analyte | Emerging Cross-Sectional Technologies | 1 | Active |
| US11774461B2 | Iron chelator-containing prothrombin time reagent | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.